Tnfa receptor1 drives hypoxia-Promoted invasiveness of human melanoma cells

Experimental Oncology

Volumn 35, Issue 3, 2013, Pages 187-191

  Marconi, C ^a   Peppicelli, S ^a   Bianchini, F ^a   Calorini, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cell invasiveness; Hs294T human melanoma cells; Hypoxia; Metalloproteinase 2 and 9; TNFa receptor 1

Indexed keywords

GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1ALPHA; MATRIGEL; MESSENGER RNA; OXYGEN; POLYCARBONATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG; AUTACOID; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL HYPOXIA; CELL INVASION; CONTROLLED STUDY; DIFFUSION; ENZYME RELEASE; FILTER; HUMAN; HUMAN CELL; MELANOMA CELL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; MELANOMA; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL HYPOXIA; CELL LINE, TUMOR; HUMANS; INFLAMMATION MEDIATORS; MELANOMA; NEOPLASM INVASIVENESS; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892151103     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47
2. Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26: 225-39
3. Pouysségur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 2006; 441: 437-43.
4. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 9: 677-84
5. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 721-32
6. Brahimi-Horn C, Pouysségur J. The role of the hypoxiainducible factor in tumor metabolism growth and invasion. Bull Cancer 2006; 93: E73-80.
7. Keith B, Simon MC. Hypoxia-inducible factors, stem cells, and cancer. Cell 2007; 129: 465-72
8. Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347-61
9. Comito G, Calvani M, Giannoni E, et al. HIF-1-α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med 2011; 51: 893-904
10. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-6
11. Chen TR. In situ detection of Mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res 1997; 104: 255-62.
12. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74
13. Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 2006; 25: 9-34
14. Sanceau J, Truchet S, Bauvois B. Matrix metalloproteinase- 9 silencing by RNA interference triggers the migratoryadhesive switch in Ewing's sarcoma cells. J Biol Chem 2003; 278: 36537-46
15. London CA, Sekhon HS, AroraV, et al. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity. Cancer Gene Ther 2003; 10: 823-32
16. Lakka SS, Rajan M, Gondi C, et al. Adenovirusmediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 2002; 21: 8011-19
17. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med 2011; 364: 656-65
18. Bianchini F, Massi D, Marconi C, et al. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression. Prostaglandins Other Lipid Mediat 2007; 83: 320-8
19. Robinson SC, Coussens LM. Soluble mediators of inflammation during tumor development. Adv Cancer Res 2005; 93: 159-87
20. Bianchini F, D'Alessio S, Fibbi G, et al. Cytokinedependent invasiveness in B16 murine melanoma cells: role of uPA system and MMP-9. Oncol Rep 2006; 15: 709-14
21. Katerinaki E, Evans GS, Lorigan PC, MacNeil S. TNF-alpha increases human melanoma cell invasion and migration in vitro: the role of proteolytic enzymes. Br J Cancer 2003; 89: 1123-9
22. Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008; 8: 887-99.
23. Ishida I, Kubo H, Suzuki S, et al. Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 2002; 169: 2069-75
24. Bristow RG, Hill RP. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8: 180-92